TScan Therapeutics, Inc. (TCRX) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.20 +0.01 (5.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $26.80 | |||
| Open | $0.20 | 52 Week Low | $23.00 | |||
| Day High | $0.20 | P/E | N/A | |||
| Day Low | $0.19 | EPS | $0.00 | |||
| Volume | 149,379 | |||||
